Drugs / mesocaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06261320 | Feb 2024 → Dec 2026 expected | inflammatory bowel disease | Polyclinique de l'Europe | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06261320 ↗ |